(Date:1/8/2009)...8 /PRNewswire-FirstCall/ - Med-Emerg International...eading providers of health services, is pleased to...ur of the previously announced plan of arrangement...AIM") at a special meeting of MedEmerg,s sharehold... votes cast at the meeting were in favour of the A...
(Date:1/8/2009)...., Jan. 8 Today, the Na...ong with several national leadership organizations...ples of hospice care and protection of the Medicar...ther in sharing this unified message about end-of-...and Palliative Medicine, Hospice and Palliative Nu...
(Date:1/8/2009)...embly Member Tom Torlakson Introduces AB 89 , ,.../ -- Today, Lung Cancer Alliance-California (LCA...son (D-11th District) for his continued leadership...lung cancer research. For the third consecutive y...rch is being considered in the California Legislat...
(Date:1/8/2009)...ered bad cholesterol more effectively than Zocor ,...After nearly a year of review, U.S. health officia... use of the controversial cholesterol-lowering dru...ion said there was no significant difference in ca...orin and patients taking the drug Zocor. , But,...
Breaking Medicine News(10 mins):Health News:Shareholders of Med-Emerg International Inc. approve plan of arrangement with AIM Health Group Inc. 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:FDA Backs Cholesterol Drug Vytorin 2...e National Health Services (NHS) patients, current...ttended to following the Government report that wo...ials had stated earlier that the maximum waiting p... they were to be admitted to a hospital by the end...
...nada: There is good news for patients afflicted b...aster, bone marrow donees and several others who a...e, invented by a researcher // at the University o...BR), is capable of scaling down the loss of transf...
...cording to scientist a new computer model has been...pidemic of malaria. The intensity whether it would...it occurs. // This would give ample time for preve...one in advance. The control of malaria is a top p...
...ientists in northern Tasmania have revealed that t...ng tumor disease affecting Tasmanian devils. // Th...also be transferred when the animals are mating, t...nne-Maree Pearse from the state's Primary Industri...
Other Medicine News:Health News:Quality Platelets and Improved Blood Availability No Longer a Pipe Dream 2Health News:Prediction of malaria epidemics possible! 2(Date:1/7/2009)...tan Puhua Hospital Stem Cells Center ( http://www....g stem cells to effectively treat neurological dis...ed additions to its medical and research staff tha...pabilities for growing numbers of incoming interna...e distinguished Dr. Jiang Ping, who was named Chie...
(Date:1/6/2009)...ire/ -- The Michael J. Fox Foundation awarded a to...h teams for pre-clinical research on potential new...nding was awarded under the Foundation,s Therapeu...launched in 2006, supports and bolsters industry-f...art of MJFF,s focus on ,de-risking, preclinical ...
(Date:1/5/2009)...lene Pharmaceuticals announced today that it has i...protein kinase inhibitor, CX-4945, in patients wit...ultiple myeloma. The primary endpoints of the oral..., tolerance and PK properties of CX-4945 and to se...addition, multiple mechanism-related pharmacodynam...
(Date:12/29/2008)...SNewswire/ -- The winner of the 2008 Award for Exc... today by Dr. Peter G. Goldschmidt, President and ..., The winner of the annual award was the Unive...or its best practice " IND Regulatory and Monitori...d human subjects protection, 2) improved data qual...
Breaking Medicine Technology:Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 32008 Human Research Protection Award Recipients Announced 2Few Employers Addressing Workplace Stress Watson Wyatt Surveys Find 11948 1Few Employers Addressing Workplace Stress Watson Wyatt Surveys Find 11948 2Few Employers Addressing Workplace Stress Watson Wyatt Surveys Find 11948 3Strategy for nanotechnology related environmental health and safety research 2209 1Strategy for nanotechnology related environmental health and safety research 2209 2IAEA helps recover stray radioactive sources in Nigeria 2204 1IAEA helps recover stray radioactive sources in Nigeria 2204 2DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference 11941 1DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference 11941 2DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference 11941 3...r 18, 2007 - Nymox,Pharmaceutical Corporation (NAS...month follow-up study of NX-1207 for benign,prosta...atic,progress of U.S. patients involved in the Com...dividuals in the study were assessed,for symptomat... of,efficacy. Patients in the study were assessed ...
...WIRE)--Apr 17, 2007 -,Seattle Genetics, Inc. (Nasd...tations by the company and its collaborators at th...for Cancer Research,(AACR) demonstrating preclinic...jugate (ADC) technology and cancer product,pipelin...killing drugs.,Seattle Genetics, ADC technology em...
Other Medicine Technology:Nymox Reports Completion of New 42 Month Follow-up Study of NX-1207,for BPH 2Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 2Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 3Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 4If you prefer a standard style iridectomy lens, then consider the Volk Iridectomy Lens. Its 8mm imaging bulb delivers the view you're used to but with the added benefit of Volk's exclusive Double Asp
...d Super Macula® 2.2 offers extremely high reso...vea, while achieving an exceptionally wide 78°...or critical evaluation of the optic nerve head and...f the macula and disc. Redesigned to reduce weight...
...Equator is designed for focal laser therapy and mi...ptical design presents a realistic contour of the ...ld view of the entire posterior pole extending to ...ws dynamic movement on the globe, therefore increa...
...0x Imaging Lens is optimized for the visible spect...ns during general diagnosis and slit lamp imaging....posterior pole and a sharper image across the diam...s also ideal for slit lamp photography. For best r...
Medicine Products: